Skip to main content
MerckPatent grant

Merck was granted a patent for arginase-inhibiting drug compounds.

Source: Autobound Signal API · 95 signals tracked for Merck · updated

Get Merck's live signals in Claude or ChatGPT, or by API

AskWhat changed at Merck this week? Use Autobound signals for merck.com.

What happened

In November 2026 Merck patented compounds intended to prevent or treat arginase-related diseases in therapeutic applications.

Source

patents.google.comNov 3, 2026

US patent US12780845

Arginase inhibitors and methods of use

Abstract

Described herein are compounds of Formula I or a pharmaceutically acceptable salt thereof. The compounds of Formula I act as arginase inhibitors and can be useful in preventing, treating or acting as a remedial agent for arginase-related diseases.

patents.google.com/patent/US12780845Read the full source

Extracted by Autobound

From the Signal API record
Signal
Patent grant

What this signalsA new patent often shows where a company is putting its R&D budget.

Grant date
Nov 3, 2026
Inventors
4
Patent number
US12780845
Assignee
Merck Sharpe & Dohme LLC

The full record

From the Signal API record

People

  • Abdelghani Abe AchabInventor
  • Matthew L. ChildersInventor
  • Christian FischerInventor
  • Symon GathiakaInventor
  • Derun LiInventor
  • Min LuInventor

Details

Primary CPC class
C07F 5/025
USPTO assignee
Merck Sharpe & Dohme LLC
What the invention does
A group of drug molecules designed to block arginase, an enzyme involved in certain disease processes.

Topics and mentions

Tags

  • Intellectual Property
  • Research & Development
  • Pharmaceuticals
  • Medical Research

Technologies named

  • arginase inhibitors
  • medicinal chemistry
  • pharmaceutical compounds

Extraction

Detected
Nov 4, 2026
signal_type
patents-company
signal_subtype
patentGrant

Use this data

Get every patent signal for Merck and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Merck this week?”

  2. Send it to your own tools

    The Signal API returns patent signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full patents-company record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/73f19da1-bcf0-5f07-af51-aad2dc9eff07 returns this record as JSON. POST /v1/companies/enrich returns every signal for merck.com.

{
  "signal_id": "73f19da1-bcf0-5f07-af51-aad2dc9eff07",
  "signal_type": "patents-company",
  "signal_subtype": "patentGrant",
  "detected_at": "2026-11-04T16:03:57+00:00",
  "company": {
    "name": "Merck",
    "domain": "merck.com"
  },
  "data": {
    "cpc": [
      {
        "code": "C07F 5/025"
      }
    ],
    "tags": [
      "Intellectual Property",
      "Research & Development",
      "Pharmaceuticals",
      "Medical Research"
    ],
    "detail": "In November 2026 Merck patented compounds intended to prevent or treat arginase-related diseases in therapeutic applications.",
    "summary": "Merck was granted a patent for arginase-inhibiting drug compounds.",
    "event_at": "2026-11-03",
    "inventors": [
      {
        "name": "Abdelghani Abe Achab",
        "status": "unresolved",
        "is_primary": true
      },
      {
        "name": "Matthew L. Childers",
        "status": "resolved",
        "is_primary": false,
        "linkedin_url": "https://www.linkedin.com/in/matthew-childers-23731967"
      },
      {
        "name": "Christian Fischer",
        "status": "resolved",
        "is_primary": false,
        "linkedin_url": "https://www.linkedin.com/in/christian-fischer-19714471"
      },
      {
        "name": "Symon Gathiaka",
        "status": "resolved",
        "is_primary": false,
        "linkedin_url": "https://www.linkedin.com/in/symon-gathiaka-b6988426"
      },
      {
        "name": "Derun Li",
        "status": "unresolved",
        "is_primary": false
      },
      {
        "name": "Min Lu",
        "status": "resolved",
        "is_primary": false,
        "linkedin_url": "https://www.linkedin.com/in/min-lu-701ab72a"
      },
      {
        "name": "Anandan Palani",
        "status": "resolved",
        "is_primary": false,
        "linkedin_url": "https://www.linkedin.com/in/anandan-palani-8769813"
      },
      {
        "name": "Rachel L Palte",
        "status": "resolved",
        "is_primary": false,
        "linkedin_url": "https://www.linkedin.com/in/rachel-palte-863b0b108"
      }
    ],
    "event_kind": "grant_date",
    "grant_date": "2026-11-03",
    "source_url": "https://patents.google.com/patent/US12780845",
    "cpc_primary": {
      "code": "C07F 5/025"
    },
    "patent_title": "Arginase inhibitors and methods of use",
    "patent_number": "US12780845",
    "uspto_assignee": "Merck Sharpe & Dohme LLC",
    "patent_abstract": "Described herein are compounds of Formula I or a pharmaceutically acceptable salt thereof. The compounds of Formula I act as arginase inhibitors and can be useful in preventing, treating or acting as a remedial agent for arginase-related diseases.",
    "precision_class": "structural",
    "invention_explanation": "A group of drug molecules designed to block arginase, an enzyme involved in certain disease processes.",
    "technologies_mentioned": [
      "arginase inhibitors",
      "medicinal chemistry",
      "pharmaceutical compounds"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.